
Butipil 2mg/0.035mg Tablet
Marketer
Sanzyme Ltd
Salt Composition
Cyproterone (2mg) + Ethinyl Estradiol (0.035mg)
Overview Butipil 2mg/0.035mg Tablet
Cyproterone acetate/Ethinylestradiol 2mg/0.035mg tablets combine two hormones to manage polycystic ovary syndrome (PCOS) symptoms like unwanted hair growth, acne, and irregular menstrual cycles. This medication also acts as birth control; therefore, avoid concurrent use of other contraceptives. These tablets may be taken with or without food, but consistent daily timing aids adherence. Dosage and treatment length vary based on your condition, but always finish the prescribed course. Common side effects include nausea, abdominal discomfort, headache, weight increase, and breast tenderness. Report any bothersome or severe side effects to your physician; management options exist. Consult your doctor about unusual mid-cycle spotting or brown discharge. Seek immediate medical attention for unexplained limb swelling and pain, breathlessness, chest pain, or vision disturbances. Discontinue use and contact your physician if menstruation doesn't begin within a week of treatment. Inform your doctor of all other medications you're using, as interactions may reduce efficacy or alter the drug's effects. Do not use this medication if you are pregnant or lactating.
Primary Ingredients of Butipil 2mg/0.035mg Tablet
No text was provided to rewrite.
Uses of Butipil 2mg/0.035mg Tablet
Managing polycystic ovary syndrome (PCOS)
Major Benefits of Butipil 2mg/0.035mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consumption of the Butipil 2mg/0.035mg Tablet may coincide with meals or be taken independently, though consistent timing is recommended.
Common Side effects of Butipil 2mg/0.035mg Tablet:
- Nausea
- Stomach pain
- Headache
- Weight gain
- Breast pain
- Mood changes
How to use Butipil 2mg/0.035mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. The Butipil 2mg/0.035mg Tablet can be consumed with or without food; however, consistent timing is recommended.
How Butipil 2mg/0.035mg Tablet works:
Each Butipil 2mg/0.035mg tablet contains Cyproterone and Ethinyl Estradiol, two hormones that synergistically manage Polycystic Ovary Syndrome (PCOS) symptoms like acne, hirsutism, and menstrual irregularities. Cyproterone's action centers on inhibiting excessive androgen production within the ovaries, thus mitigating acne and excessive hair growth. Ethinyl Estradiol complements this by lowering circulating androgens, further enhancing the therapeutic effect. This combined action also contributes to the normalization of menstrual cycles in patients with PCOS.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while taking Butipil 2mg/0.035mg tablets. Seek medical advice.
PregnancyUNSAFE
Use of Butipil 2mg/0.035mg tablets is strongly contraindicated during pregnancy. Pregnant individuals should consult a physician, as research in both animal and human subjects indicates substantial risks to fetal development.
Breast feedingCONSULT YOUR DOCTOR
Administering Butipil 2mg/0.035mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Butipil 2mg/0.035mg tablets.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Butipil 2mg/0.035mg tablets in patients with renal impairment is scarce. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Butipil 2mg/0.035mg tablets in individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Butipil 2mg/0.035mg Tablet :
Should you forget to take a Butipil 2mg/0.035mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Butipil 2mg/0.035mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | OBSTETRIC AND GYNECOLOGICAL |
